NANoREG D1 11

NANoREG D4 15 DR Protocol for inhalation exposure and choice of biological relevant endpoints

Acesse:

https://www.rivm.nl/en/documenten/nanoreg-d4-15-dr-protocol-for-inhalation-exposure-and-choice-of-biological-relevant 

NANoREG D2.08 SOP 02 For measurement of hydrodynamic Size-Distribution and Dispersion Stability by DLS

Acesse:

https://www.rivm.nl/en/documenten/nanoreg-d208-sop-02-for-measurement-of-hydrodynamic-size-distribution-and-dispersion

NANoREG D5.03 DR In vitro screening methodology for absorption or crossing of other barriers

Acesse:

https://www.rivm.nl/en/documenten/nanoreg-d503-dr-in-vitro-screening-methodology-for-absorption-or-crossing-of-other 

SOPs available in deliverable:

• SOP 01 Protocol for organotypic cell culture modified for exposure to nanomaterials
• SOP 02 Caco-2 cell culture and differentiation
• SOP 03 Evaluation of NMs impact on Caco-2 cell barrier model

NANoREG D4.02 DR Provide histological samples from chronic study

Acesse:

https://www.rivm.nl/documenten/nanoreg-d402-dr-provide-histological-samples-from-chronic-study 

NANoREG D3.04 DR Improved data for the modelling of the exposure to MNMs

Acesse:

https://www.rivm.nl/en/documenten/nanoreg-d304-dr-improved-data-for-modelling-of-exposure-to-mnms

NANoREG D5.07 SOP 05 Viability protocol by using a Cell Counter

Acesse:

https://www.rivm.nl/documenten/nanoreg-d507-sop-05-viability-protocol-by-using-a-cell-counter